Article
Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.
Immunology - 1 Nov 2012
Haenisch Britta, Nöthen Markus M, Molderings Gerhard J
Abstract excerpt
Despite increasing understanding of its pathophysiology, the aetiology of systemic mast cell activation disease (MCAD) remains largely unknown. Research has shown that somatic mutations in kinases are necessary for the establishment of a clonal mast cell population, in particular mutations in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
